Company Quick10K Filing
Acquired Sales
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-15
S-1 2019-08-02 Public Filing
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-13
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-10-05
10-Q 2018-03-31 Filed 2018-10-03
10-K 2017-12-31 Filed 2018-09-26
10-Q 2017-09-30 Filed 2018-09-19
10-Q 2017-06-30 Filed 2018-09-19
10-Q 2017-03-31 Filed 2018-09-18
10-K 2016-12-31 Filed 2018-09-06
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-28
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-04-01
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-17
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-13
10-Q 2012-03-31 Filed 2012-05-21
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-K 2010-09-30 Filed 2010-12-20
10-Q 2010-06-30 Filed 2010-08-23
10-Q 2010-03-31 Filed 2010-05-18
10-Q 2009-12-31 Filed 2010-02-16
8-K 2020-04-21 Off-BS Arrangement
8-K 2020-02-24 M&A, Sale of Shares, Control, Officers, Exhibits
8-K 2020-01-07 Enter Agreement, Exhibits
8-K 2019-11-14 Leave Agreement, Exhibits
8-K 2019-08-15 Enter Agreement, Exhibits
8-K 2019-07-29 Amend Bylaw, Exhibits
8-K 2019-06-21 Enter Agreement, Exhibits
8-K 2019-05-23 Other Events, Exhibits
8-K 2019-05-08 Sale of Shares, Other Events, Exhibits
8-K 2019-04-30 Enter Agreement, Exhibits
8-K 2019-02-12 Enter Agreement, Sale of Shares, Officers, Amend Bylaw, Exhibits
8-K 2018-11-18 Other Events, Exhibits
8-K 2018-06-29 Accountant, Other Events

Acquired Sales Financials

AQSP Metrics, Comps, Filings

Quarterly | Annual

Business

Description of the Business of Acquired Sales Corp.

Acquired Sales Corp. (hereinafter sometimes referred to as "Acquired Sales", the "Company", "AQSP", "Acquired", the "Company", "we", "us", "our", etc.) was organized under the laws of the State of Nevada on January 2, 1986.

The Company currently is a shell corporation and does not currently have any business or any sources of revenue.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
flooidCX (GRPV) 21,817 -11.2 -4,072% 48 3,441 0 0 -1,947 -1,947 21,806
Non Invasive Monitoring Systems (NIMU) 21,673 -14.9 -434% 337 311 0 0 -1,463 -1,429 21,340
Franklin Wireless (FKWL) 21,669 15% -17.0 -5% 21,195 5,921 30,018 4,363 -1,120 -898 15,221
Quantum Materials (QTMM) 21,666 0% -3.0 -359% 2,067 7,192 8 0 -7,413 -7,145 21,531
Newbridge Global Ventures (NBGV) 21,547 0% -3.6 -31% 22,306 9,397 10 0 -6,974 -6,498 23,224
Velt (VIGC) 21,528 100% -19.3 -9% 12,999 120 6 6 -1,115 -1,115 21,524
Rego Payment Architectures (RPMT) 21,527 0% -11.5 -466% 511 22,392 34 0 -2,384 -1,869 21,505
Central Federal Bancshares (CFDB) 21,504 55.7 0% 69,041 43,820 0 0 47 301 16,775
New Jersey Mining (NJMC) 21,214 13% 158.1 -3% 11,164 2,157 4,545 585 -357 132 20,933
Biotricity (BTCY) 21,039 57% -3.0 -765% 1,058 5,956 969 551 -8,093 -8,093 24,639
ChineseInvestors.com (CIIX) 18,649 21% -1.7 -230% 4,424 7,640 7,189 1,541 -10,191 -10,034 17,337
Acquired Sales (AQSP) 20,859 -15.6 -17% 6,556 104 0 0 -1,088 -1,060 16,500
Hooper Holmes (HH) 20,612 21% -3.6 -59% 30,232 46,988 61,285 13,115 -17,873 -10,726 38,613
China YCT International Group (CYIG) 20,589 43% -0.6 15% 114,301 5,348 75,798 32,456 17,715 24,133 -15,374
Evergreen (EVGI) 20,582 -378.3 -6,931% 1 61 0 0 -54 -54 20,581
Green Spirit (GSRX) 20,213 46% -0.7 -194% 15,098 3,560 9,062 4,152 -29,296 -29,296 19,103
US Nuclear (UCLE) 20,177 51% -9.9 -54% 3,848 1,508 2,819 1,426 -2,063 -2,047 20,272
Texas South Energy (TXSO) 19,984 -5.4 -26% 14,729 9,196 0 0 -3,770 -3,667 19,799
Midwest Energy Emissions (MEEC) 19,950 28% -17.6 -14% 9,250 17,178 8,893 2,454 -1,326 -1,078 19,006
Sun Biopharma (SNBP) 19,872 -4.9 -137% 3,820 1,431 0 0 -5,226 -3,369 16,495

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1875022172094271,3701,281678588374217842814101000000002,7974,3414,359
Accounts Receivable615885752382922300
Inventory
PP&E575256402,31454
Assets7172191,2501,0118631,0991,9531,5351,4271,3701,2811,3051,2341,040994845314101000000002,7976,2396,556
Accounts Payable42940133241634613794192151265825485213192953105929510210410610911211011321227
Long-Term Debt4544664714800031
Liabilities3,6713,1163,3383,4344,172395202169415126582548521319295710914916919221022824826729733918086104
Stockholders' Equity-2,954-2,897-2,088-2,423-3,3097041,7511,3661,3861,3191,2551,2471,2099929427233-16-56-109-148-169-192-210-228-248-267-297-3392,6176,1536,451
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue184059591,643140
Cost of Revenue0192316483104
Gross Profit1821364321936
R&D
SG&A6962,0021,008745748281757210460239745338494053-6317161616171717264562
Tax010000100000000
Net Income-694-1,809-525-4793,7421,046-38570-67253-8-5,182-217-50-870-38-49-40-53-20-23-18-18-20-91-35-44-897-146
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-17-50331-133-28577-51-37-89-0-165-214-62-92-32-39-17-04-1-0000-162-185-141
Cash Investing-921-03,6700-863001,0000-60275-40-2525000000-300
Cash Financing9246040-2,2520-30-20000-42,9593,625459